> Skip repeated content

Outcomes in Pediatric Fractures of the Medial Epicondyle: A Prospective Registry

IRB Number: 10085

June 10, 2010

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Daniel W. Green, MD


Roger F. Widmann, MD
John S. Blanco,  MD
David M. Scher, MD
Shevaun M. Doyle, MD
Peter Fabricant, MD


This study prospectively enrolls pediatric patients with acute avulsion of the medial epicondyle treated with operative and non-operative means and follows daily function and athletic function as well as radiographic outcomes, symptomatic outcomes, and physical exam.

Inclusion/Exclusion Criteria

Inclusion criteria:

Patients between the ages of 9 and 18 who experience an acute onset of elbow pain with radiographic evidence of avulsion fracture of the medial epicondyle will be included in our study.

Exclusion criteria:

Our study will exclude the following patients: patients over the age of 18, and patients with prior surgery or injury to the ipsilateral extremity.

Contact Information

Daniel W. Green, MD